PD12: Bladder Cancer: Basic Research & Pathophysiology II

Podium Session Moderator(s)

• 

  Byron Lee, MD, PHD

  Cleveland Clinic
• 

  Peter Black, MD

  University of British Columbia
• SK

  Seok Ho Kang

Presentations:

• 1:20 PM – 1:30 PM

  PD12-03: Interferon &[alpha] gene therapy alters tumor metabolism in bladder cancer
  

  Podium Presenter: Jan Krzysztof Rudzinski, MD, FRCSC, MSc – Faculty of Medicine University of Calgary
• 1:30 PM – 1:40 PM

  PD12-04: Survey of B and Plasma Cells in Bladder Cancer Across Tumor Microenvironments
  

  Podium Presenter: Yuanshuo Alice Wang, PHD, BS
• 1:40 PM – 1:50 PM

  PD12-05: Spatial Transcriptomics Provides Evidence for Alternative Checkpoint Axes in BCG-treated NMIBC
  

  Podium Presenter: Daniel Ranti, BS
• 1:50 PM – 2:00 PM

  PD12-06: Differential myeloid inflammatory response and tumorigenesis by gender in mouse model of bladder cancer
  

  Podium Presenter: Lauren Folgosa Cooley
• 2:00 PM – 2:10 PM

  PD12-07: Addition of Anti-PD-L1 Enhances Antitumor Efficacies of BCG and BCG-STING by CD8+ T Cell expansion in a Murine Syngeneic MB49 Model of Urothelial Carcinoma
  

  Podium Presenter: Kara Lombardo, BS
• 2:10 PM – 2:20 PM

  PD12-08: Cryotherapy for Superficial Bladder Cancer in a Swine Model
  

  Podium Presenter: Gilad E. Amiel, MD – RAMBAM Medical Center and Technion Medical School
• 2:20 PM – 2:30 PM

  PD12-09: Elevated Semaphorin-6A facilitates FLT4-meditated tumor migration and associates with immune suppression in bladder cancer.
  

  Podium Presenter: Wenjie Luo, MD, MS – Fudan University Shanghai Cancer Center
• 2:30 PM – 2:40 PM

  PD12-10: Urine Comprehensive Genomic Profiling of urothelial carcinoma patients undergoing intravesical therapy enables detection of actionable DNA mutations associated with drug response and risk stratification
  

  Podium Presenter: Goran Rac, MD
• 2:40 PM – 2:50 PM

  PD12-11: Castration Impact on Pattern Recognition Receptors (PRRs) Boosts Toll-Like Receptor-4 Expression in an Immunocompetent Bladder Cancer Male Model
  

  Podium Presenter: Leonardo O. Reis, MD, PHD, MSC
• 2:50 PM – 3:00 PM

  PD12-12: Tumor antigen vaccine enhances anti-tumor effects of Immune checkpoint inhibitors against refractory cancers.
  

  Podium Presenter: Shohei Ueda